Product features
Indirect chemiluminescent immunoassay (CLIA) to test IgG antibodies against Strongyloides stercoralis in human serum/plasma.
- Excellent sensitivity (94%) and specificity (93%)
- Adapted to urgent diagnosis - Rapid, automated protocol, results in around 1h
- No sample cumulation compared to the only existing ELISA’s in the market
- Full compatibility with the VirClia portfolio +90 assays
PRODUCTS
STRONGYLOIDES STERCORALIS VIRCLIA® IgG MONOTEST
USED ON
VirClia® Lotus
A compact automated CLIA platform for VirClia® infectious disease testing, combining ready-to-use single-test flexibility with continuous random access efficiency.
MORE RESOURCES
Downloadable PDF materials, brochures, and technical documents.
The latest insights, news, and research articles from our scientific team.
H. pylori stool antigen testing: when the test works, but the workflow no longer does
Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...
Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Beyond detection: H. pylori testing in today’s laboratory workflow
Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...
Scientific bibliography and references related to this product.
